Document Detail

The new concept of ''interventional heart failure therapy'': part 2--inotropes, valvular disease, pumps, and transplantation.
MedLine Citation:
PMID:  20595625     Owner:  NLM     Status:  MEDLINE    
Recent advances in heart failure therapy include a variety of mechanical and device-based technologies that target structural aspects of heart failure that cannot be treated with drug therapy alone; these newer therapies can collectively be described as interventional heart failure therapy. This article is the second in a 2-part series reviewing interventional heart failure therapy. Interventions included in this discussion include those indicated for the treatment of end-stage refractory heart failure, including interventional medical therapy, interventional treatment of valvular disease, mechanical assist devices, and heart transplantation. Also included is a review of the currently available catheter-based pumps, which are intended to provide temporary support in patients with acute hemodynamic compromise. The use of cellular or stem cell therapy for the treatment of heart failure is an emerging interventional therapy and data supporting its use for the treatment heart failure will also be presented, as will a discussion of the role of palliative care and self-care in heart failure therapy.
Keith A Thompson; Kiran J Philip; Sinan Simsir; Ernst R Schwarz
Related Documents :
14499855 - The cardiovascular effects of erythropoietin.
8572995 - Biomedicus ventricular assistance for postcardiotomy heart failure: evaluation of unive...
20024475 - Pattern of heart failure in abuja, nigeria: an echocardiographic study.
12193525 - Clinical course and medical management of neonates with severe cardiac failure related ...
20214535 - Choline in acute coronary syndrome: an emerging biomarker with implications for the int...
4008775 - Automatic pacemaker termination of two different types of supraventricular tachycardia.
Publication Detail:
Type:  Journal Article; Review     Date:  2010-07-01
Journal Detail:
Title:  Journal of cardiovascular pharmacology and therapeutics     Volume:  15     ISSN:  1940-4034     ISO Abbreviation:  J. Cardiovasc. Pharmacol. Ther.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-10     Completed Date:  2010-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602617     Medline TA:  J Cardiovasc Pharmacol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  231-43     Citation Subset:  IM    
Department of Medicine, Division of Cardiology, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiotonic Agents / therapeutic use
Heart Failure / drug therapy,  surgery,  therapy*
Heart Transplantation
Heart Valve Diseases / drug therapy,  surgery,  therapy*
Heart-Assist Devices
Palliative Care
Self Care
Stem Cell Transplantation
Reg. No./Substance:
0/Cardiotonic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects a...
Next Document:  Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion in...